Cargando…
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
Development of biofluid-based molecular diagnostic tests for cancer is an important step towards tumor characterization and real-time monitoring in a minimally invasive fashion. Extracellular vesicles (EVs) are released from tumor cells into body fluids and can provide a powerful platform for tumor...
Autores principales: | Chen, Walter W, Balaj, Leonora, Liau, Linda M, Samuels, Michael L, Kotsopoulos, Steve K, Maguire, Casey A, LoGuidice, Lori, Soto, Horacio, Garrett, Matthew, Zhu, Lin Dan, Sivaraman, Sarada, Chen, Clark, Wong, Eric T, Carter, Bob S, Hochberg, Fred H, Breakefield, Xandra O, Skog, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732870/ https://www.ncbi.nlm.nih.gov/pubmed/23881452 http://dx.doi.org/10.1038/mtna.2013.28 |
Ejemplares similares
-
OMRT-2. Liquid biopsy for patient stratification and monitoring of dacomitinib clinical trial in patients with EGFR amplified recurrent glioblastoma
por: Yekula, Anudeep, et al.
Publicado: (2021) -
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls
por: Noerholm, Mikkel, et al.
Publicado: (2012) -
Heparin affinity purification of extracellular vesicles
por: Balaj, Leonora, et al.
Publicado: (2015) -
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
por: Shao, Huilin, et al.
Publicado: (2015) -
miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development
por: Akers, Johnny C., et al.
Publicado: (2013)